Microvascular Obstruction Diagnosis Using the CoFI™ System Assessment - II
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 200 participants.
Also called NCT06909578
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 200 participants
- Sponsor
- CorFlow Therapeutics AG
- Registry
-
NCT06909578
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06909578. Allocation not applicable; no masking; primary purpose diagnostic. Start 2025-09-01 (anticipated); primary completion 2026-12-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Microvascular Obstruction Diagnosis Using the CoFI™ System Assessment - II
- Acronym
- MOCA II
- Condition
- Microvascular Obstruction (MVO)
- Condition
- STEMI - ST Elevation Myocardial Infarction
- Intervention (Device)
- CorFlow Controlled Flow Infusion System - CoFI™
- Lead sponsor
- CorFlow Therapeutics AG
Record details
- Record id
cardio:ct-nct06909578- Content hash
185e577f369d87c31fca0391191cad8346b2fe9f9b0dbfa0cc0d0b458deb868a